Shanghai Sunland Industrial Co., Ltd is the top manufacturer of Personal Protect Equipment in China, with 20 years’experience. We are the Chinese government appointed manufacturer for government power,personal protection equipment , medical instruments,construction industry, etc. All the products get the CE, ANSI and related Industry Certificates. All our safety helmets use the top-quality raw material without any recycling material.
The difference between 17 and 14 types of protective clothing
We provide exclusive customization of the products logo, using advanced printing technology and technology, not suitable for fading, solid and firm, scratch-proof and anti-smashing, and suitable for various scenes such as construction, mining, warehouse, inspection, etc. Our goal is to satisfy your needs. Demand, do your best.
Professional team work and production line which can make nice quality in short time.
The professional team provides 24 * 7 after-sales service for you, which can help you solve any problems
Address：No. 3888, Hutai Road, Baoshan District, Shanghai, China
Testing of ,Covid-19, IgM and IgG is an effective method for the rapid ,detection, of ,COVID-19, antibodies. Presence of ,COVID-19, IgM antibodies indicates a recent exposure to ,COVID-19,, whereas ,detection, of ,COVID-19, IgG antibodies indicates a later stage of infection.
COVID-19, testing involves analyzing samples to assess the current or past presence of SARS-CoV-2.The two main branches detect either the presence of the virus or of antibodies produced in response to infection. Tests for viral presence are used to diagnose individual cases and to allow public health authorities to trace and contain outbreaks.
The approved COVID-19 test kits for commercial use are: Nucleic acid detection kit, manufactured by Shanghai GenoeDx Biotech Co. Ltd.-Shanghai, China. It is distributed by S&S Enterprise. Novel coronavirus 2019 nucleic acid detection kit (fluorescence PCR method), manufactured by Beijing Applied Biological Technologies Co. Ltd.
In early 2020, CDC developed its first laboratory test ,kit, for ,use, in testing patient specimens for SARS-CoV-2. The test ,kit, is called the CDC 2019 Novel ,Coronavirus, (2019-nCoV) Real-Time Reverse Transcriptase (RT)–PCR Diagnostic Panel.. On February 3, 2020, CDC submitted an EUA package to expedite FDA-permitted ,use, of the CDC diagnostic panel in the United States.
Our newly developed real-time PCR ,kit, for SARS-CoV-2 pathogen ,detection, research is now available to order. Our singleplex ,kit, workflow was developed for ,use, on the Applied Biosystems QuantStudio 5 or 7500 real time PCR systems. The ,kit, utilizes Applied Biosystems TaqMan Assay technology, enabling specific, sensitive, and accurate results.